Now accepting Telehealth appointments. Schedule a virtual visit.

Transcranial Magnetic Stimulation (TMS) Off-Label Uses

Depression is a leading cause of disability for adults aged 15-44 in the United States. Fortuantely, there are many treatments and therapy that are available to individuals experiencing this condition. Transcranial magnetic stimulation (TMS) is an FDA approved treatment for treatment resistant depression. However, the magnetic stimulation from TMS also has other off label uses that can be used to alleviate and/or treat other illnesses as well. 

Ongoing, yet promising research continued with TMS use for other conditions. It is studied extensively across disorder and even disciplines with the hope that it could advance treatments for neurological disorder, pain management, and physical rehabilitation along with psychiatry. There are currently ongoing large clinical studies investigating the effectiveness of TMS in conditions such a generalized anxiety disorder, post traumatic stress disorder, pediatric depression, bipolar disorder, smoking cessation, chronic pain, and obsessive-compulsive disorder. While these treatments have not been FDA approved, there are plenty of scientific-backed evidence that TMS use to treat these disorders are effective. 

Here is a list of peer reviewed articles for the appropriate condition:

Depression and Anxiety 

Obsessive Compulsion Disorder

Complex Regional Pain Syndrome

Smoking Cessation 

Post Traumaumatic Sress Disorder 

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).